[go: up one dir, main page]

AU2017902737A0 - Treatment of ocular conditions - Google Patents

Treatment of ocular conditions

Info

Publication number
AU2017902737A0
AU2017902737A0 AU2017902737A AU2017902737A AU2017902737A0 AU 2017902737 A0 AU2017902737 A0 AU 2017902737A0 AU 2017902737 A AU2017902737 A AU 2017902737A AU 2017902737 A AU2017902737 A AU 2017902737A AU 2017902737 A0 AU2017902737 A0 AU 2017902737A0
Authority
AU
Australia
Prior art keywords
treatment
ocular conditions
ocular
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017902737A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Invert Graphite Ltd
Original Assignee
Factor Therapeutics Ltd
Filing date
Publication date
Application filed by Factor Therapeutics Ltd filed Critical Factor Therapeutics Ltd
Publication of AU2017902737A0 publication Critical patent/AU2017902737A0/en
Priority to PCT/AU2018/050717 priority Critical patent/WO2019010533A1/en
Abandoned legal-status Critical Current

Links

AU2017902737A 2017-07-12 2017-07-12 Treatment of ocular conditions Abandoned AU2017902737A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2018/050717 WO2019010533A1 (en) 2017-07-12 2018-07-12 Treatment of ocular conditions

Publications (1)

Publication Number Publication Date
AU2017902737A0 true AU2017902737A0 (en) 2017-07-27

Family

ID=

Similar Documents

Publication Publication Date Title
EP3177732A4 (en) Compositions and methods for the treatment of ophthalmic diseases and conditions
EP3160405A4 (en) Treatment of the ear
EP3716997A4 (en) Methods of treatment with asparaginase
EP3554505A4 (en) Methods of treating ocular disorders
EP3209295A4 (en) Methods of treating ocular conditions
GB2541840B (en) Ophthalmic composition for the treatment of ocular infection
IL270362B (en) Treatment of glaucoma
EP3503965B8 (en) Treatment of cardiac dysfunction
EP3302382A4 (en) Implant for treatment of an ocular condition
EP3658218A4 (en) Treatment of eye disorders
EP3717647A4 (en) Mir29 mimics for the treatment of ocular fibrosis
EP3448377A4 (en) Methods for the treatment of infection
EP3271017A4 (en) Treatment of skin conditions
AU2017902737A0 (en) Treatment of ocular conditions
EP3129054A4 (en) Methods and compositions for the treatment of ocular diseases and disorders
HK40107008A (en) New treatment of sma
EP4034125A4 (en) Treatment of excitotoxicity-related conditions
HK40038038A (en) Methods of treatment of hypertrigl yceridemia
HK40032171A (en) Combination treatment of sarcoglycanopathies
HK40040885A (en) Polysaccharides for the treatment of ocular conditions
HK40004067A (en) Methods of treating ocular conditions
AU2019903588A0 (en) Treatment of excitotoxicity-related conditions
AU2017904906A0 (en) Methods of treatment
AU2017902346A0 (en) Methods of treating ocular disorders
HK40021761A (en) Methods of preventing or treating ophthalmic diseases